<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="152">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04391712</url>
  </required_header>
  <id_info>
    <org_study_id>2020.01</org_study_id>
    <nct_id>NCT04391712</nct_id>
  </id_info>
  <brief_title>Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease</brief_title>
  <official_title>Multiwave Locked System (MLS) Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lowell General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lowell General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the effectiveness of MLS laser therapy as a treatment
      for pulmonary complications due to COVID-19 infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be randomized into treatment vs. control group. Both groups will receive
      regular inpatient medical treatment. Participants in the experimental arm will receive laser
      treatments once daily for 4 days. Treatments will be delivered to the patients in a prone
      position using a 10 by 25 cm laser field across each lung with 7j/cm2 at 1500 Hz. Standard
      nursing protocols would be used to identify participant's pulmonary status throughout
      treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 30, 2020</start_date>
  <completion_date type="Actual">July 16, 2020</completion_date>
  <primary_completion_date type="Actual">May 15, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This study will utilize a randomized parallel assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Disposition Post treatment</measure>
    <time_frame>7 days</time_frame>
    <description>ICU on vent, ICU not requiring ventilation, Discharge to Rehab requiring assistance, Discharge to Home unable to perform ADL's, Discharge to Home able to perform ADL's</description>
  </primary_outcome>
  <primary_outcome>
    <measure>oxygenation</measure>
    <time_frame>Daily for 4 days</time_frame>
    <description>Patients oxygen requirements pulse oximetry will be evaluated for change from pre and post individual treatment as well as end of protocol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IL-6 levels</measure>
    <time_frame>First four days of trial</time_frame>
    <description>The change in pre treatment levels and 24 hours post final treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Chest Xray radiographic results</measure>
    <time_frame>7 Days</time_frame>
    <description>Pre treatment CXR will be compared to post treatment CXR using the RALE CXR evaluation scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Brescia-COVID Respiratory Severity Scale</measure>
    <time_frame>7 days</time_frame>
    <description>The change in pretreatment and post treatment BCRSS will be evaluated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SMART-COP Score</measure>
    <time_frame>7 days</time_frame>
    <description>The change in pretreatment and post treatment scores will be evaluated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PSI Score</measure>
    <time_frame>7 days</time_frame>
    <description>The change in pretreatment and post treatment scores will be evaluated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CRP levels</measure>
    <time_frame>7 days</time_frame>
    <description>The change in pretreatment and post treatment levels will be evaluated The change in pretreatment and post treatment levels will be evalutated</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive MLS laser treatment along with regular inpatient medical care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive regular inpatient medical care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MLS Laser</intervention_name>
    <description>Treatments will be delivered to the participants days 1-4, in a prone position using a 10 by 25 cm laser field across each lung with 7j/cm2 at 1500 Hz.</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Regular Inpatient Medical Care</intervention_name>
    <description>Regular inpatient medical care</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COVID-19 positive

          -  Pulmonary compromise requiring oxygen support of approximately 2-6 liters

          -  Able to self prone, or support in self-sitting position

        Exclusion Criteria:

          -  Ventilator management

          -  Patients with autoimmune disorders or inflammatory conditions not related to COVID-19

          -  Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott Sigman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lowell General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lowell General Hospital</name>
      <address>
        <city>Lowell</city>
        <state>Massachusetts</state>
        <zip>01854</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>May 4, 2020</study_first_submitted>
  <study_first_submitted_qc>May 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2020</study_first_posted>
  <last_update_submitted>August 3, 2020</last_update_submitted>
  <last_update_submitted_qc>August 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lowell General Hospital</investigator_affiliation>
    <investigator_full_name>Scott Sigman, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>COVID</keyword>
  <keyword>Laser</keyword>
  <keyword>Pulmonary</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

